APA (7th ed.) Citation

E, V., I, N., A, P., D, C., M, D., K, R., . . . E, T. (2018). Denosumab in transfusion-dependent thalassemia osteoporosis: A randomized, placebo-controlled, double-blind phase 2b clinical trial. Blood advances, 2(21), 2837. https://doi.org/10.1182/bloodadvances.2018023085

Chicago Style (17th ed.) Citation

E, Voskaridou, Ntanasis-Stathopoulos I, Papaefstathiou A, Christoulas D, Dimopoulou M, Repa K, Papatheodorou A, Peppa M, and Terpos E. "Denosumab in Transfusion-dependent Thalassemia Osteoporosis: A Randomized, Placebo-controlled, Double-blind Phase 2b Clinical Trial." Blood Advances 2, no. 21 (2018): 2837. https://doi.org/10.1182/bloodadvances.2018023085.

MLA (9th ed.) Citation

E, Voskaridou, et al. "Denosumab in Transfusion-dependent Thalassemia Osteoporosis: A Randomized, Placebo-controlled, Double-blind Phase 2b Clinical Trial." Blood Advances, vol. 2, no. 21, 2018, p. 2837, https://doi.org/10.1182/bloodadvances.2018023085.